Nanexa AB
Industry · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Phase 1 Study Assessing the Pharmacokinetics of NEX-22A in Subjects With T2D Type 2 Diabetes | Phase 1 | 2024-05-27 |
| Completed | To Assess Safety, Tolerability and PK of NEX-20A, a Subcutaneous Prolonged-release Injection to Healthy Subjec Multiple Myeloma | EARLY_Phase 1 | 2022-11-28 |
| Completed | Pharmacokinetics, Tolerability and Safety of NEX-18a Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML), Acute Myeloid Leukemia (AML) | Phase 1 | 2021-04-27 |